23andMe gets FDA go-ahead to provide pharmacogenetic reports on statin
The US FDA provided 510(k) clearance for 23andMe to provide drug information for simvastatin based on the genetics of users of the service.
The US FDA provided 510(k) clearance for 23andMe to provide drug information for simvastatin based on the genetics of users of the service.
Altasciences is expanding its facility in Columbia, Missouri to provide bioanalytical services in support of preclinical and clinical studies conducted in the US.
The Association of Clinical Research Organizations (ACRO) has released a question and answer document to support the adoption of decentralized clinical trials (DCT).